Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SAB Biotherapeutics (SABS) Treasury Shares: 2022-2024

Historic Treasury Shares for SAB Biotherapeutics (SABS) over the last 3 years, with Dec 2024 value amounting to $54,665.

  • SAB Biotherapeutics' Treasury Shares changed negligibly% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $5.5 million for FY2024, which is negligibly% changed negligibly from last year.
  • Per SAB Biotherapeutics' latest filing, its Treasury Shares stood at $5.5 million for FY2024, which was down 0.00% from $5.5 million recorded in FY2023.
  • In the past 5 years, SAB Biotherapeutics' Treasury Shares registered a high of $5.5 million during FY2022, and its lowest value of $5.5 million during FY2022.
  • Its 3-year average for Treasury Shares is $18,222, with a median of $54,665 in 2024.
  • Per our database at Business Quant, SAB Biotherapeutics' Treasury Shares plummeted by 200.00% in 2023 and then skyrocketed by 200.00% in 2024.
  • Yearly analysis of 3 years shows SAB Biotherapeutics' Treasury Shares stood at $54,665 in 2022, then slumped by 200.00% to -$54,665 in 2023, then soared by 200.00% to $54,665 in 2024.